Upper Limb Rehabilitation After Stroke Assisted With a Hybrid Electrical Stimulation (ES)-Robot System
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Apr 15, 2014
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well a special robot and electrical stimulation can help people recover movement in their arms after having a stroke. The researchers want to see if using both the robot and electrical stimulation together is better than traditional therapy alone for people who have had a stroke and experience difficulties with their arm movements.
To participate in this study, individuals must be between 65 and 74 years old or between 25 and 66 years old and have had a stroke that affected one side of their body at least six months ago. They should have some motor difficulties with their affected arm, but still be able to follow instructions and have enough muscle activity in their arm to participate. Participants can expect to engage in a rehabilitation program that combines the robot and electrical stimulation, which aims to improve their arm function. This study is currently recruiting, and all genders are welcome to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • The recruited subjects will
- • have unilateral ischemic brain injury or intracerebral hemorrhage at least 6 months after the onset of single stroke
- • have moderate level of motor impairment in the affected upper limb, assessed by Fugl-Meyer Assessment (9\<shoulder/elbow\<27; 6\<wrist/hand\<18)
- • have enough cognition to be able to follow the training protocol as assessed by Mini-metal State Examination (MMSE\>21)
- • have detectable EMG signals (3 times of the standard deviation above the baseline) from the upper limb muscles.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , China
Patients applied
Trial Officials
Xiaoling Hu, Ph.D.
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials